CRIS Curis Inc.

0.84
+0.04  (+5%)
Previous Close 0.8
Open 0.81
Price To Book 41.99
Market Cap 27811731
Shares 33,113,146
Volume 747,863
Short Ratio
Av. Daily Volume 393,432

SEC filingsSee all SEC filings

  1. S-8 - Securities to be offered to employees in employee benefit plans 181235664
  2. 10-Q - Quarterly report [Sections 13 or 15(d)] 181152030
  3. 8-K - Current report 181151956
  4. 8-K - Current report 181091422
  5. 10-Q - Quarterly report [Sections 13 or 15(d)] 18986674

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 1 data due mid-2019.
CA-4948
Relapsed or Refractory Non-Hodgkin Lymphoma
Phase 1 data for Mesothelioma due 2H 2019.
CA170
Solid Tumors and Lymphomas
Approved January 30, 2012.
Vismodegib
Basal Cell Carcinoma
Initial data in DH/DE DLBCL 2H 2019.
Fimepinostat (CUDC-907) and venetoclax
Diffuse-large B-cell lymphoma (DLBCL)

Latest News

  1. Analysis: Positioning to Benefit within Dicerna Pharmaceuticals, Sun Life Financial, Autodesk, Eagle Pharmaceuticals, Curis, and Accenture — Research Highlights Growth, Revenue, and Consolidated Results
  2. Curis to Present at the 60th Annual Meeting of the American Society of Hematology
  3. Curis to Present at 33rd Society for Immunotherapy of Cancer Annual Meeting and Cowen IO NEXT Summit
  4. Edited Transcript of CRIS earnings conference call or presentation 1-Nov-18 12:30pm GMT
  5. Curis (CRIS) Reports Q3 Loss, Tops Revenue Estimates
  6. Curis: 3Q Earnings Snapshot
  7. Curis Reports Third Quarter 2018 Financial Results
  8. Curis to Release Third Quarter Financial Results and Hold Conference Call on November 1, 2018
  9. Investor Expectations to Drive Momentum within Ormat Technologies, The Andersons, Freshpet, Curis, Ultra Clean, and Edge Therapeutics — Discovering Underlying Factors of Influence
  10. Curis (CRIS) Shares March Higher, Can It Continue?
  11. Top 3 Healthcare Penny Stocks for 2018
  12. Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
  13. Who Are The Top Investors In Curis Inc (NASDAQ:CRIS)?
  14. Curis to Present at the Cantor Fitzgerald Global Healthcare Conference
  15. Curis Announces Leadership Change
  16. Curis to Present at the Baird 2018 Global Healthcare Conference
  17. Edited Transcript of CRIS earnings conference call or presentation 2-Aug-18 12:30pm GMT
  18. Curis (CRIS) Reports Q2 Loss, Lags Revenue Estimates

SEC Filings

  1. S-8 - Securities to be offered to employees in employee benefit plans 181235664
  2. 10-Q - Quarterly report [Sections 13 or 15(d)] 181152030
  3. 8-K - Current report 181151956
  4. 8-K - Current report 181091422
  5. 10-Q - Quarterly report [Sections 13 or 15(d)] 18986674
  6. 8-K - Current report 18986609
  7. SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals 18945955
  8. CT ORDER - Confidential treatment order 18943717
  9. 8-K/A [Amend] - Current report 18869688
  10. 8-K - Current report 18865403